Sirolimus delays renal allograft recovery

被引:9
作者
Davis, C [1 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1034/j.1600-6143.2003.00116.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Concern is growing that sirolimus use may prolong renal dysfunction in the early period after renal transplant, leading to new recommendations to delay its use in renal allografts. See also article by McTaggart et al. in this issue on page 416.
引用
收藏
页码:363 / 365
页数:3
相关论文
共 17 条
[1]   Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506 [J].
Andoh, TF ;
Burdmann, EA ;
Fransechini, N ;
Houghton, DC ;
Bennett, WM .
KIDNEY INTERNATIONAL, 1996, 50 (04) :1110-1117
[2]  
ANDOH TF, 2002, AM J TRANSPLANT, V3, P161
[3]   A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function [J].
Chang, GJ ;
Mahanty, HD ;
Vincenti, F ;
Freise, CE ;
Roberts, JP ;
Ascher, NL ;
Stock, PG ;
Hirose, R .
CLINICAL TRANSPLANTATION, 2000, 14 (06) :550-554
[4]   Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody [J].
Gonwa, TA ;
Mai, ML ;
Melton, LB ;
Smith, D ;
Levy, MF ;
Goldstein, RM ;
Klintmalam, GB .
CLINICAL TRANSPLANTATION, 2002, 16 (02) :144-149
[5]   Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft [J].
Grinyo, JM ;
Gil-Vernet, S ;
Seron, D ;
Hueso, M ;
Fulladosa, X ;
Cruzado, JM ;
Moreso, F ;
Fernandez, A ;
Torras, J ;
Riera, L ;
Castelao, AM ;
Alsina, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) :2601-2604
[6]   Sirolimus (rapamycin)-based therapy in human renal transplantation -: Similar efficacy and different toxicity compared with cyclosporine [J].
Groth, CG ;
Bäckman, L ;
Morales, JM ;
Calne, R ;
Kreis, H ;
Lang, P ;
Touraine, JL ;
Claesson, K ;
Campistol, JM ;
Durand, D ;
Wramner, L ;
Brattström, C ;
Charpentier, B .
TRANSPLANTATION, 1999, 67 (07) :1036-1042
[7]   Use of anti-CD25 monoclonal antibody in combination with rapamycin to eliminate cyclosporine treatment during the induction phase of immunosuppression [J].
Hong, JC ;
Kahan, BD .
TRANSPLANTATION, 1999, 68 (05) :701-704
[8]   Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study [J].
Kahan, BD .
LANCET, 2000, 356 (9225) :194-202
[9]   Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy [J].
Lebranchu, Y ;
Bridoux, F ;
Büchler, M ;
Le Meur, Y ;
Etienne, I ;
Toupance, O ;
de Ligny, BH ;
Touchard, G ;
Moulin, B ;
Le Pogamp, P ;
Reigneau, O ;
Guignard, M ;
Rifle, G .
AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (01) :48-56
[10]   Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells [J].
Lieberthal, W ;
Fuhro, R ;
Andry, CC ;
Rennke, H ;
Abernathy, VE ;
Koh, JS ;
Valeri, R ;
Levine, JS .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (04) :F693-F706